Origin and Spread of Evolving Artemisinin-Resistant Plasmodium falciparum Malarial Parasites in Southeast Asia
- 4 December 2019
- journal article
- review article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 101 (6) , 1204-1211
Abstract
In this review, we provide an epidemiological history of the emergence and ongoing spread of evolving Plasmodium falciparum artemisinin resistance (ARTR). Southeast Asia has been the focal point for emergence and spread of multiple antimalarial drug resistance phenomena, and is once again for evolving ARTR, also known as the “delayed clearance phenotype” (DCP). The five countries most impacted, Cambodia, Thailand, Myanmar, Laos, and Vietnam, each have complex histories of antimalarial drug use over many decades, which have in part molded the use of various artemisinin combination therapies (ACTs) within each country. We catalog the use of ACTs, evolving loss of ACT efficacy, and the frequency of pfk13 mutations (mutations associated with ARTR) in the Greater Mekong Subregion and map the historical spread of ARTR/DCP parasites. These data should assist improved surveillance and deployment of next-generation ACTs.Keywords
This publication has 111 references indexed in Scilit:
- Multiple populations of artemisinin-resistant Plasmodium falciparum in CambodiaNature Genetics, 2013
- Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast AsiaProceedings of the National Academy of Sciences, 2012
- Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal studyThe Lancet, 2012
- A Major Genome Region Underlying Artemisinin Resistance in MalariaScience, 2012
- Phenotypic and Genotypic Analysis of In Vitro -Selected Artemisinin-Resistant Progeny of Plasmodium falciparumAntimicrobial Agents and Chemotherapy, 2012
- Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border areaMalaria Journal, 2011
- Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malariaProceedings of the National Academy of Sciences, 2011
- Increased Tolerance to Artemisinin in Plasmodium falciparum Is Mediated by a Quiescence MechanismAntimicrobial Agents and Chemotherapy, 2010
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- Evidence of Artemisinin-Resistant Malaria in Western CambodiaNew England Journal of Medicine, 2008